Last week, the Vanderbilt Bill Wilkerson Center co-hosted the 8th Quadrennial Internal Conference on Vestibular Schwannoma and Other CPA (cerebellopontine angle) Tumors in partnership with Mayo Clinic.

Armed with $1.2 million in funding from the National Heart, Lung and Blood Institute (NHLBI), researchers at Vanderbilt University Medical Center are searching to understand the cause of a rare airway disease in hopes of developing better treatments.

Gaelyn Garrett, MD, MMHC, was recently inducted as the first female president of the American Laryngological, Rhinological and Otological Society.

Early diagnosis of head and neck cancer greatly increases odds of survival, but its symptoms can be subtle or mimic viral infections, so Vanderbilt Health offers a free screening annually.

Stanford University School of Medicine’s Lloyd Minor, MD, center, spoke about health care in the era of precision medicine during his recent Flexner Discovery Lecture.

An international team involving Vanderbilt researchers has discovered that a new “checkpoint” protein on immune system cells is active in tumors, and that blocking it — in combination with other treatments — is a successful therapeutic approach in mouse models of cancer.

Vanderbilt University Medical Center’s David Zealear, PhD, has received a $3.6 million grant from the National Institutes of Health (NIH) for a clinical trial to study the effectiveness of bilateral laryngeal pacing in treating patients with a bilaterally paralyzed larynx.